Search
Search Results
- Publication:
- [Boston, Massachusetts] : Institute for Clinical and Economic Review, April 7, 2017
- Subject(s):
- Arthritis, Rheumatoid -- drug therapy
Arthritis, Rheumatoid -- immunology
Immunologic Factors -- therapeutic use
Abatacept -- therapeutic use
Adalimumab -- therapeutic use
Antirheumatic Agents -- adverse effects
Antirheumatic Agents -- therapeutic use
Certolizumab Pegol -- therapeutic use
Cost-Benefit Analysis
Drug Therapy, Combination
Etanercept -- therapeutic use
Immunologic Factors -- adverse effects
Infliximab -- therapeutic use
Interleukin-6 -- antagonists & inhibitors
Janus Kinase Inhibitors -- therapeutic use
Randomized Controlled Trials as Topic
Rituximab -- therapeutic use
Tumor Necrosis Factors -- antagonists & inhibitors
Humans
United States
- Author(s):
- Tice, Jeffrey A., author
Ollendorf, Daniel A., author
Pearson, Steven D., author
- Publication:
- [Boston, MA] : Institute for Clinical and Economic Review, April 15, 2014
- Subject(s):
- Comparative Effectiveness Research
Hepatitis C, Chronic -- drug therapy
Heterocyclic Compounds, 3-Ring -- therapeutic use
Sulfonamides -- therapeutic use
Uridine Monophosphate -- analogs & derivatives
Uridine Monophosphate -- therapeutic use
Antiviral Agents -- economics
Antiviral Agents -- therapeutic use
Cost-Benefit Analysis
Drug Costs
Drug Therapy, Combination
Genotype
Hepatitis C -- economics
Hepatitis C -- genetics
Heterocyclic Compounds, 3-Ring -- adverse effects
Heterocyclic Compounds, 3-Ring -- economics
Insurance Coverage
Interferon-alpha -- therapeutic use
Oligopeptides -- therapeutic use
Polyethylene Glycols -- therapeutic use
Proline -- analogs & derivatives
Proline -- therapeutic use
Protease Inhibitors -- economics
Protease Inhibitors -- therapeutic use
Randomized Controlled Trials as Topic
Ribavirin -- therapeutic use
Sulfonamides -- adverse effects
Technology Assessment, Biomedical
Treatment Outcome
Uridine Monophosphate -- adverse effects
Uridine Monophosphate -- economics
Value-Based Purchasing
Humans
United States
- Publication:
- [Boston, MA] : Institute for Clinical and Economic Review, December 2014
- Subject(s):
- Comparative Effectiveness Research
Diabetes Mellitus, Type 2 -- drug therapy
Disease Management
Blood Glucose -- analysis
Blood Glucose -- metabolism
Dipeptidyl-Peptidase IV Inhibitors -- therapeutic use
Drug Therapy, Combination
Hemoglobin A, Glycosylated -- analysis
Hypoglycemic Agents -- administration & dosage
Hypoglycemic Agents -- therapeutic use
Insulin -- therapeutic use
Metformin -- administration & dosage
Metformin -- therapeutic use
Monitoring, Ambulatory
Randomized Controlled Trials as Topic
Receptors, Glucagon -- agonists
Sulfonylurea Compounds -- administration & dosage
Sulfonylurea Compounds -- therapeutic use
Treatment Outcome
Humans
New England
United States
- Author(s):
- Carter, Elizabeth A., author
Purvis, Leigh, author
- Publication:
- Washington, DC : AARP Public Policy Institute, August 2018
- Subject(s):
- Dementia -- drug therapy
Dementia -- economics
Drug Costs
Inappropriate Prescribing -- economics
Aged
Cholinesterase Inhibitors -- economics
Cholinesterase Inhibitors -- therapeutic use
Cost Savings
Drug Therapy, Combination
Memantine -- economics
Memantine -- therapeutic use
Humans
United States
- Author(s):
- Makam, Anil N., author
Nikitin, Dmitriy, author
Richardson, Marina, author
Mohammed, Rasheed, author
McKenna, Avery, author
Pearson, Steven D., author
Rind, David M., author
Suh, Kangho, author
Carlson, Josh J., author
- Publication:
- [Boston, Massachusetts] : Institute for Clinical and Economic Review, September 13, 2022
- Subject(s):
- Amyotrophic Lateral Sclerosis -- drug therapy
Drug Therapy, Combination
Edaravone -- therapeutic use
Phenylbutyrates -- therapeutic use
United States